Xufeng Guo

机构：Gansu Agricultural University, Shanghai Jiao Tong University, Shanghai Chest Hospital · ORCID：0000-0001-9684-7107

发表论文 27 篇 · 总被引 256 次 · h-index 7

代表论文

• Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma (2025 · JAMA Surgery · 被引 78)
• Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets (2022 · Frontiers in Immunology · 被引 37)
• High glucose contributes to the proliferation and migration of non-small-cell lung cancer cells via GAS5-TRIB3 axis (2018 · Bioscience Reports · 被引 35)
• The clinical characteristics, treatments and prognosis of post-esophagectomy airway fistula: a multicenter cohort study (2022 · Translational Lung Cancer Research · 被引 16)
• Hyperoside inhibited the migration and invasion of lung cancer cells through the upregulation of PI3K/AKT and p38 MAPK pathways. (2017 · PubMed · 被引 11)
• Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world study (2025 · International Journal of Surgery · 被引 8)